These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23806101)

  • 21. Indoxyl-beta-D-glucuronide and 3-indoxyl sulfate in plasma of hemodialysis patients.
    Agatsuma S; Sekino H; Watanabe H
    Clin Nephrol; 1996 Apr; 45(4):250-6. PubMed ID: 8861801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional genomic analysis identifies indoxyl sulfate as a major, poorly dialyzable uremic toxin in end-stage renal disease.
    Jhawar S; Singh P; Torres D; Ramirez-Valle F; Kassem H; Banerjee T; Dolgalev I; Heguy A; Zavadil J; Lowenstein J
    PLoS One; 2015; 10(3):e0118703. PubMed ID: 25811877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients.
    Bammens B; Evenepoel P; Keuleers H; Verbeke K; Vanrenterghem Y
    Kidney Int; 2006 Mar; 69(6):1081-7. PubMed ID: 16421516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of impaired olfactory function in ESRD to malnutrition and retained uremic molecules.
    Raff AC; Lieu S; Melamed ML; Quan Z; Ponda M; Meyer TW; Hostetter TH
    Am J Kidney Dis; 2008 Jul; 52(1):102-10. PubMed ID: 18423810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair.
    Dou L; Bertrand E; Cerini C; Faure V; Sampol J; Vanholder R; Berland Y; Brunet P
    Kidney Int; 2004 Feb; 65(2):442-51. PubMed ID: 14717914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a sustained difference in hemodialytic clearance on the plasma levels of p-cresol sulfate and indoxyl sulfate.
    Camacho O; Rosales MC; Shafi T; Fullman J; Plummer NS; Meyer TW; Sirich TL
    Nephrol Dial Transplant; 2016 Aug; 31(8):1335-41. PubMed ID: 27190347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of residual function to removal of protein-bound solutes in hemodialysis.
    Marquez IO; Tambra S; Luo FY; Li Y; Plummer NS; Hostetter TH; Meyer TW
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):290-6. PubMed ID: 21030575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with blood concentrations of indoxyl sulfate and p-cresol in patients undergoing peritoneal dialysis.
    Lee CT; Kuo CC; Chen YM; Hsu CY; Lee WC; Tsai YC; Ng HY; Kuo LC; Chiou TT; Yang YK; Cheng BC; Chen JB
    Perit Dial Int; 2010; 30(4):456-63. PubMed ID: 20338972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral disease in adults treated with hemodialysis: prevalence, predictors, and association with mortality and adverse cardiovascular events: the rationale and design of the ORAL Diseases in hemodialysis (ORAL-D) study, a prospective, multinational, longitudinal, observational, cohort study.
    Strippoli GF; Palmer SC; Ruospo M; Natale P; Saglimbene V; Craig JC; Pellegrini F; Petruzzi M; De Benedittis M; Ford P; Johnson DW; Celia E; Gelfman R; Leal MR; Torok M; Stroumza P; Bednarek-Skublewska A; Dulawa J; Frantzen L; Ferrari JN; del Castillo D; Hegbrant J; Wollheim C; Gargano L;
    BMC Nephrol; 2013 Apr; 14():90. PubMed ID: 23597063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial.
    Sirich TL; Fong K; Larive B; Beck GJ; Chertow GM; Levin NW; Kliger AS; Plummer NS; Meyer TW;
    Kidney Int; 2017 May; 91(5):1186-1192. PubMed ID: 28089366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered Serum n-6 Polyunsaturated Fatty Acid Profile and Risks of Mortality and Cardiovascular Events in a Cohort of Hemodialysis Patients.
    Kuwamura Y; Shoji T; Okute Y; Yamazaki Y; Motoyama K; Morioka T; Mori K; Fukumoto S; Tsujimoto Y; Shioi A; Emoto M; Inaba M
    J Ren Nutr; 2018 Jan; 28(1):54-63. PubMed ID: 29089279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction in protein-bound solutes unacceptable as marker of dialysis efficacy during alternate-night nocturnal hemodialysis.
    Meijers B; Toussaint ND; Meyer T; Bammens B; Verbeke K; Vanrenterghem Y; Kerr PG; Evenepoel P
    Am J Nephrol; 2011; 34(3):226-32. PubMed ID: 21791919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    Etinger A; Kumar SR; Ackley W; Soiefer L; Chun J; Singh P; Grossman E; Matalon A; Holzman RS; Meijers B; Lowenstein J
    PLoS One; 2018; 13(2):e0192770. PubMed ID: 29470534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dental Health and Mortality in People With End-Stage Kidney Disease Treated With Hemodialysis: A Multinational Cohort Study.
    Palmer SC; Ruospo M; Wong G; Craig JC; Petruzzi M; De Benedittis M; Ford P; Johnson DW; Tonelli M; Natale P; Saglimbene V; Pellegrini F; Celia E; Gelfman R; Leal MR; Torok M; Stroumza P; Bednarek-Skublewska A; Dulawa J; Frantzen L; Ferrari JN; Del Castillo D; Bernat AG; Hegbrant J; Wollheim C; Gargano L; Bots CP; Strippoli GF;
    Am J Kidney Dis; 2015 Oct; 66(4):666-76. PubMed ID: 26120038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease.
    Lin CJ; Chen HH; Pan CF; Chuang CK; Wang TJ; Sun FJ; Wu CJ
    J Clin Lab Anal; 2011; 25(3):191-7. PubMed ID: 21567467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between Serum Uric Acid and Mortality Risk in Hemodialysis Patients: A Multicenter Prospective Cohort Study.
    Yang Y; Qin X; Li Y; Yang S; Chen J; He Y; Huang Y; Lin Z; Li Y; Kong Y; Lu Y; Zhao Y; Wan Q; Wang Q; Huang S; Liu Y; Liu A; Liu F; Hou FF; Liang M
    Am J Nephrol; 2020; 51(10):823-832. PubMed ID: 33070128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations of Posthemodialysis Weights above and below Target Weight with All-Cause and Cardiovascular Mortality.
    Flythe JE; Kshirsagar AV; Falk RJ; Brunelli SM
    Clin J Am Soc Nephrol; 2015 May; 10(5):808-16. PubMed ID: 25862779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients.
    Mallamaci F; Zoccali C; Parlongo S; Tripepi G; Benedetto FA; Cutrupi S; Bonanno G; Fatuzzo P; Rapisarda F; Seminara G; Stancanelli B; Bellanuova I; Cataliotti A; Malatino LS
    Am J Kidney Dis; 2002 Jul; 40(1):68-75. PubMed ID: 12087563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastrointestinal-related uremic toxins in peritoneal dialysis: a pilot study with a 5-year follow-up.
    Lin CJ; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ
    Arch Med Res; 2013 Oct; 44(7):535-41. PubMed ID: 24055267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An update on protein-bound uremic retention solutes.
    Vanholder R; Schepers E; Pletinck A; Neirynck N; Glorieux G
    J Ren Nutr; 2012 Jan; 22(1):90-4. PubMed ID: 22200422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.